Introduction
Translocator protein (TSPO) is an 18 kDa protein located at contact sites between the outer and the inner mitochondrial membranes, which was previously known as peripheral benzodiazepine receptor (PBR), due to its property to bind diazepam (Papadopoulos et al., 2006; Batarseh and Papadopoulos, 2010 ).
This protein is arranged in five transmembrane alpha helices and presents a cholesterol recognition amino acid consensus (CRAC) domain at its C-terminal region, presenting high-affinity for cholesterol (Li and Papadopoulos, 1998; Jaremko et al., 2014) . Functionally, TSPO is thought to mediate the translocation of cholesterol across the aqueous mitochondrial intermembrane space, and due to this function, this protein was renamed in 2006 as TSPO (Papadopoulos et al., 2006 by other molecules involved in the transport of cholesterol into the mitochondria such as: (i), the voltage-dependent anion channel (VDAC); (ii), the 67-kDa long isoform of the adenosine triphosphatase (ATPase) family, AAA domain-containing protein 3 (ATAD3) and (iii), the steroidogenic acute regulatory protein (StAR) (Midzak et al., 2011; Rone et al., 2012; Issop et al., 2015) . The transport of cholesterol into the mitochondria is the ratelimiting step in steroidogenesis. In the mitochondria, the biosynthesis of steroids is initiated with the enzymatic cleavage of the side chain of cholesterol by the cytochrome P450 side chain cleavage enzyme (CYP11A1), which forms the first steroid, pregnenolone (Miller and Auchus, 2011) . Pregnenolone, then, leaves the mitochondria towards the endoplasmic reticulum, where it undergoes further enzymatic transformations that will form the final steroid products, including progesterone, testosterone and estradiol (Lacapère and Papadopoulos, 2003) . In addition to its relationship with the regulation of cholesterol transport and steroidogenesis, TSPO is thought to mediate other mitochondrial functions, such as mitochondrial respiration and cell proliferation and differentiation (Hirsch et al., 1989; Corsi et al., 2008) . Moreover, TSPO has been associated with the control of the mitochondrial permeability transition pore (MPTP) opening, therefore regulating cytochrome C release, caspase activation and apoptosis (Zamzami and Kroemer, 2001; Azarashvili et al., 2007; Sileikyte et al., 2011) .
TSPO is widely distributed throughout the body, being found in most tissues, including the adrenal, pineal and salivary glands, the olfactory epithelium, ependyma, gonads, heart, kidney, liver, lung, bone, marrow, brain, spinal cord and peripheral nerves (Batarseh and Papadopoulos, 2010; Hernstadt et al., 2009 ). In the nervous system, the expression of TSPO in physiological conditions is low, however, this protein is upregulated at sites of injury and inflammation, as well as in several neuropathological conditions including stroke and neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease, Huntington's disease, multiple sclerosis and amyotrophic lateral sclerosis Pavese et al., 2006; Edison et al., 2008; Yasuno et al., 2008; Rissanen et al., 2014; Zürcher et al., 2015) . Some studies have shown that TSPO ligands may be neuroprotective in experimental models of different neurodegenerative diseases, as well as in experimental models of brain injuries and psychiatric disorders (see Arbo et al. (2015) for review). In addition, Girard et al. (2008) have shown that the TSPO ligand etifoxine is able to improve nerve regeneration and functional recovery after nerve transection in rats. Furthermore, Giatti et al. (2009) demonstrated that the TSPO ligand 4 0 -chlorodiazepam (4 0 -CD, also known as Ro5-4864) is able to increase the levels of pregnenolone, progesterone and dihydrotestosterone in the sciatic nerves of diabetic rats and to decrease the severity of diabetic peripheral neuropathy. In relation to AD, it was observed that 4 0 -CD exerts neuroprotective actions in a mouse model of AD, reducing hippocampal amyloid-beta (Aβ)-40 accumulation and gliosis, and improving the functional outcomes of 3xTgAD mice . AD pathological hallmarks include the presence of extracellular senile plaques mainly composed of Aβ peptide and intracellular neurofibrillary tangles formed by hyper-phosphorilated aggregates of tau, which is a microtubule-associated protein (Cavallucci et al., 2012) . Aβ accumulation causes neuronal damage in AD through the activation of pro-apoptotic pathways (Nikolaev et al., 2009; Vohra et al., 2010; Zhou et al., 2011 ) and contributes to the formation of intracellular neurofibrillary tangles, which further accelerates neuronal loss and causes the symptoms of dementia (Takata and Kitamura, 2012) . It is known that Aβ downregulates the expression of Bcl-2, an anti-apoptotic protein, and upregulates the expression of Bax, a pro-apoptotic protein, regulating neuronal survival through the modulation of the balance between pro-apoptotic and anti-apoptotic proteins (Paradis et al., 1996; Selznick et al., 2000; Clementi et al., 2006) . Therefore, the aim of this study was to identify the neuroprotective effects of 4 0 -CD against amyloid-beta (Aβ) in SHSY-5Y neuroblastoma cells and its mechanisms of action.
Results

4 0 -CD is neuroprotective against Aβ induced neurotoxicity
To assess its neuroprotective effects, four different doses of 4 0 -CD were tested against Aβ-induced neurotoxicity. It was observed that 4 0 -CD was neuroprotective against Aβ when administered at 1 nM or 10 nM (F (6,30) ¼8.093, Po0.0001) ( Fig. 1 ). However, when cells were treated with higher doses of 4 0 -CD (100 nM or 1 μM), its neuroprotective effect disappeared. Based on these findings, we selected the dose of 10 nM to be used in the subsequent experiments.
The neuroprotective effect of 4 0 -CD against Aβ is related with the modulation of the protein expression of Bax and survivin
After the identification of the neuroprotective effect elicited by 4 0 -CD administration against Aβ-induced neurotoxicity, we studied the expression of some proteins implicated in the regulation of cell survival and apoptosis, namely Bax, survivin, Bcl-xl and procaspase-3, which could mediate the neuroprotective effects of 4 0 -CD. We observed that Aβ increased the protein expression of Bax (F (3, 20) ¼ 5.916, P¼ 0.0046) (Fig. 2) and decreased the protein expression of survivin (F (3,18) ¼ 3.454, P¼ 0.0385) (Fig. 3) , while the concomitant administration of 4 0 -CD inhibited these effects. No differences were found in the expression of Bcl-xl (Fig. 4 ) and procaspase-3 (Fig. 5) between the experimental groups.
Discussion
In the last decade, several studies have assessed the neuroprotective actions of TSPO ligands in different experimental models. These compounds, which are currently used for brain imaging of neuroinflammation due to the upregulation of TSPO in reactive microglia and astrocytes, have been shown to be neuroprotective in different experimental models of neurodegenerative diseases, brain injuries and psychiatric disorders (as reviewed by Arbo et al. (2015) . In this study, we observed that the TSPO ligand 4 0 -CD was neuroprotective against Aβ treatment in female human neuroblastoma cells. These data corroborate previous data by Barron et al. (2013) , which found that 4 0 -CD was neuroprotective in a mouse model of AD, reducing hippocampal Aβ-40 accumulation and gliosis, and improving the functional outcomes of 3xTgAD mice.
As previously mentioned, it is known that Aβ may affect neuronal survival through the modulation of the balance between pro-apoptotic and anti-apoptotic proteins (Paradis et al., 1996) . We observed here that Aβ neurotoxicity was associated with a decreased expression of survivin, which was reversed by the co-administration of 4 0 -CD. Survivin is a downstream protein of the β-catenin pathway and a member of the inhibitor of apoptosis protein family, which exerts 
anti-apoptotic effects by inhibiting caspase activation and activated caspases, including caspase-3 and -7 (Tamm et al., 1998; Shin et al., 2001 ). Although we did not observe changes in the levels of procaspase-3, survivin could be acting modulating its cleavage into the active caspase-3, whose levels were not detected in the Western-blots. Indeed, data suggest that although survivin tightly binds to active caspases such as caspase-3 and -7, it may not bind to its inactive proforms, acting mainly by inhibiting the activated caspases and regulating caspase activation by preventing the cleavage of its proforms (Tamm et al., 1998) . Therefore, this could explain the fact that the changes in the levels of survivin were not correlated with significant differences between the levels of procaspase-3. In addition, it should be mentioned that the role of caspase-3 in the Aβ-induced neuronal death is still controversial, as studies have suggested that Aβ neurotoxicity may be also caspase-independent (Selznick et al., 2000; Dumanchin-Njock et al., 2001; Yu et al., 2010; Yu et al., 2011) . In addition to the modulation of survivin protein expression, the neuroprotective effects of 4 0 -CD were also associated with a decreased protein expression of Bax. As previously mentioned, several studies have shown that Aβ-induced neuronal damage is associated with the modulation of the balance between pro-apoptotic and anti-apoptotic proteins, including the upregulation of Bax and the downregulation of anti-apoptotic proteins from the Bcl-2 family (Paradis et al., 1996; Selznick et al., 2000; Clementi et al., 2006) . Bax is a proapoptotic protein from the Bcl-2 protein family that is found mainly in the cytosol as soluble monomers, and to a lesser extent, loosely associated to mitochondria (Dejean et al., 2006) . Bax activity is under the control of prosurvival members of the Bcl-2 family, including Bcl-2 and Bcl-xl, which heterodimerize with Bax and other pro-apoptotic proteins, inhibiting their activation (Chipuk et al., 2010) . After apoptotic stimulation, Bax undergoes conformational changes and is translocated from the cytosol to the mitochondria, where it regulates the formation of pores and leads to the mitochondrial outer membrane permeabilization (MOMP), resulting in the release of cytochrome c and other pro-apoptotic factors from the mitochondria, which lead to caspase activation and apoptosis (Gillies et al., 2015) . Therefore, the neuroprotective actions of 4 0 -CD against Aβ could be related with a downregulation of Bax expression, which could be associated with decreased cytochrome c release and increased cell viability. Although the changes in the Bax expression were not directly related to significant changes in the expression of Bcl-xl, other proteins of the Bcl-2 family such as Bcl-2 could be involved in the regulation of Bax expression after 4 0 -CD treatment.
As previously mentioned, functionally, TSPO is thought to regulate cholesterol transport and steroidogenesis (Midzak et al., 2011; Rone et al., 2012; Arbo et al., 2015) . Therefore, one of the hypothesis regarding the neuroprotective effects of TSPO ligands against Aβ is that the activation of TSPO could be related with the stimulation of the biosynthesis of neurosteroids, which could mediate the neuroprotective effects of TSPO ligands. Regarding this aspect, it is known that estradiol is able to regulate the expression of proteins from the Bcl-2 family, decrease mitochondrial cytochrome c release and protect cortical and hippocampal neurons against Aβ (Nilsen et al., 2006; Yao et al., 2007) . These data were corroborated by another study, which found that estradiol protects cerebellar granule cells against Aβ through a reduction in the Aβ-induced upregulation of Bax and downregulation of Bcl-xl, inhibiting mitochondrial cytochrome c release and apoptosis (Napolitano et al., 2014) . Moreover, Qin et al. (2015) demonstrated that progesterone is neuroprotective against Aβ-induced neurotoxicity in primary cultured rat cortical neurons through the inhibition of JNK signaling and the inhibition of the mitochondrial apoptotic pathway. More recently, Grimm et al. (2015) showed that different neurosteroids, including progesterone, estradiol and testosterone, are able to rescue the bioenergetics deficits induced by the overexpression of Aβ in SHSY-5Y cells. In addition, other study showed that both estradiol and progesterone are able to regulate the expression of Aβ clearance factors in primary neuron cultures and female rat brain (Jayaraman et al., 2012) , corroborating a possible role of neurosteroids in the regulation of Aβ actions in the brain. On the other hand, it is also known that neurosteroidogenesis is affected by Aβ in SH-SY5Y cells (Schaeffer et al., 2008) and that 3xTg-AD mice show age-related changes in neuroactive steroid levels , corroborating the relationship between Aβ and these molecules. Therefore, as 4 0 -CD elicit neuroprotection against Aβ through similar mechanisms than neurosteroids, including the modulation of the balance between pro-apoptotic and anti-apoptotic proteins, it is possible that these effects could be mediated by increased neurosteroidogenesis, and this hypothesis should be tested by further studies. In summary, we showed that 4 0 -CD is neuroprotective against Aβ-induced neurotoxicity and that this effect may be related with the inhibition of Aβ-induced downregulation of survivin and upregulation of Bax. Further studies may investigate if the neuroprotective effects of 4 0 -CD against Aβ are mediated by increased neurosteroidogenesis related to the stimulation of TSPO activity.
Experimental procedure
Chemicals
Dimethyl sulfoxide (DMSO), 4 0 -CD, retinoic acid (RA), fluorescein diacetate (FDA) and propidium iodide (PI) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Culture mediums were purchased from Invitrogen (Invitrogen, Crewe, UK). Aβ 1-40 was supplied by Polypeptide (Strasbourg, France).
Cell cultures
Female human SH-SY5Y neuroblastoma cells (American Type Culture Collection, Manassas, VA, USA) were grown in Dulbecco's Modified Eagle Medium/Nutrient F-12 Ham (DMEM F12) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 1% of antibiotics. Cells were maintained at 371 C in a saturated humidity atmosphere containing 95% air and 5% CO 2 . They were passaged twice per week and were not used after 10 passages.
4.3.
Evaluation of the neuroprotective effects of 4 0 -CD against Aβ induced neurotoxicity
After reaching 80% confluence, cells were seeded into 48-well plates (for viability assays) or into 6-well plates (for Western Blot analysis). In order to obtain differentiated cells, they were cultured with RA (10 μM) for six days as described elsewhere (Guarneri et al., 2000; Jantas et al., 2014) and the culture medium was changed every two days during this period. Five hours before treatments, cells were washed with phosphate buffered solution (PBS) and incubated with fresh serum-free medium. Cells were pre-treated for 1 h with DMSO or 4 0 -CD (1 nM, 10 nM, 100 nM and 1000 nM), and then exposed to vehicle (PBS) or Aβ 1-40 (12 μM, solubilized in PBS at 37 1C for 24 h in order to obtain aggregated Aβ) plus DMSO or 4 0 -CD in the doses previously described for 24 h. The dose of Aβ used in this study was based in a pilot study (data not shown).
Cell viability assays
To assess cell viability we performed the fluorescein diacetate (FDA)/propidium iodide (PI) assay (Astiz et al., 2014) . FDA is a cell-permeant esterase substrate that stain live cells. Living cells actively convert the non-fluorescent FDA into the green compound fluorescein. FDA assay allows the evaluation of cell-membrane integrity, which is required for intracellular retention of its fluorescent product. In contrast, PI is a membrane impermeable compound commonly used for the identification of dead cells. After treatments, cells were incubated for 50 min at 37 1C with FDA (100 μM) and PI (15 μM). After that, cells were washed with culture medium and plates were read in a fluorimeter. The viability ratio is expressed by the ratio of the FDA/PI absorbance and is given as percentage of control, and at least four independent experiments were performed.
Western blotting
After viability assay, cells were homogenized in lysis buffer (pH 7.4) containing protease inhibitors and detergents (150 mM NaCl, 20 mM Tris-HCl, 5 mM EDTA, 10% glycerol, 0.5% Nonidet P40 and protease inhibitor cocktail). The homogenates were centrifuged at 14000 Â g for 5 min at 4 1C to discard cell debris, and the supernatant fraction obtained was used for Western blot assay. After protein isolation, the samples were boiled for 5 min. The protein levels were measured by the method of Bradford (1976) . After protein measurement, sodium dodecyl sulfate polyacrilamide gel electrophoresis (SDS-PAGE) on 12 or 15% (w/v) was carried out using a mini-protean system (Bio-Rad, Hercules, CA, USA) with broad range molecular weight standards (Precision Plus Protein Dual Color Standards, Bio-Rad). Protein (25 mg) was loaded in each lane with loading buffer containing 65 mM Tris (pH¼ 6.8), 50% glycerol, 10% SDS, 0.5 M mercaptoethanol, 0.002% bromophenol blue. Samples were heated at 94 1C for 2 min prior to gel loading. After electrophoresis, proteins were transferred to 0.2 μm nitrocellulose membranes (Trans-Blot, Bio-Rad) by a semi-dry system 25 V, 2.5 A, 5 min (Trans-Blot Turbo Transfer System, Bio-Rad). The membranes were blocked with 5% (w/v) BSA in TTBS (138 mM NaCl, 25 mM Tris, pH 8.0, and 0.1% (w/v) Tween-20) at room temperature for 2 h, and then incubated overnight at 4 1C with the primary antibody diluted in this same blocking solution. The membranes were processed for immunodetection using rabbit polyclonal antibodies for survivin (16 kDa) (1:1000 dilution) (Cell Signaling, Danvers, MA, USA), Bax (23 kDa) (1:500 dilution) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), Bcl-xl (30 kDa) (1:50 dilution) (Santa Cruz) and procaspase-3 (32 kDa) (1:1000 dilution) (BD Biosciences, San Jose, CA, USA). After washing with TTBS, the membranes were incubated for 2 h at room temperature with goat antirabbit (Jackson ImmunoResearch, West Grove, PA, USA) or goat anti-mouse (Bio-Rad) peroxidase-conjugate secondary antibodies (1:10000 dilution) and washed with TBS (20 mM Tris-HCl, 140 mM NaCl, pH¼7.4). The blots were revealed for chemiluminescence followed by apposition of the membranes to autoradiographic films (Hyperfilm ECL, Amersham). The densitometric analysis of the autoradiographies was performed with the image ImageJ software (NIH, Bethesda, MD, USA). The results from each membrane were normalized to β-actin (42 kDa) (1:4000 dilution) (Sigma-Aldrich) or glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (36 kDa) (1:1000 dilution) (Millipore, Billerica, MA, USA) where indicated. To minimize interassay variations, samples from all experimental groups were processed in parallel. Protein expression values were calculated as arbitrary densitom etric units.
4.6.
Statistical analysis
Statistical analysis was carried out using GraphPad Prism 5.0 software (La Jolla, CA, USA). A one-way analysis of variance (one-way ANOVA) was performed to evaluate cell viability and protein expression between different groups. When appropriate, ANOVA was followed by the Student-Newman-Keuls (SNK) post hoc test. All results were expressed as mean7standard error (SEM). The level of statistical significance was set at Po0.05.
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